TY - JOUR
TI - Rosuvastatin-induced thrombocytopenia
AU - Vrettos, I.
AU - Papageorgiou, S.
AU - Economopoulou, C.
AU - Pappa, V.
AU - Tsirigotis, P.
AU - Tountas, N.
AU - Economopoulos, T.
AU - Dervenoulas, J.
JO - Southern Medical Journal
PY - 2010
VL - 103
TODO - 7
SP - 676-678
PB - 
SN - 0038-4348, 1541-8243
TODO - 10.1097/SMJ.0b013e3181e170f5
TODO - C reactive protein;  electrolyte;  hemoglobin;  rosuvastatin;  tumor marker, aged;  anamnesis;  appendectomy;  article;  aspiration;  blood cell count;  blood smear;  bone marrow biopsy;  case report;  cell structure;  drug withdrawal;  dyslipidemia;  echography;  eosinophil;  erythrocyte sedimentation rate;  erythropoiesis;  female;  human;  kidney function test;  leukocyte count;  liver function test;  lymphocyte;  megakaryocyte;  monocyte;  myelopoiesis;  neutrophil;  physical examination;  thorax radiography;  thrombocyte count;  thrombocytopenia;  thyroid function test;  treatment duration;  vitiligo, Aged;  Dyslipidemias;  Female;  Fluorobenzenes;  Humans;  Hydroxymethylglutaryl-CoA Reductase Inhibitors;  Pyrimidines;  Sulfonamides;  Thrombocytopenia
TODO - Rosuvastatin, a statin indicated for patients with primary hypercholesterolemia, mixed dyslipidemia and familial hypercholesterolemia, is well tolerated by most patients. Its most common adverse effects are gastrointestinal derangement, muscle aches and hepatitis. One rare complication of statin treatment is severe thrombocytopenia. The case of a 65-year-old patient who developed severe thrombocytopenia while on rosuvastatin is presented, in addition to a review of the literature. Copyright © 2010 by The Southern Medical Association.
ER -